What is Amgen's SG&A?

Amgen (AMGN) reported SG&A of $1.6B in Q1 2026.

How has Amgen's SG&A changed year-over-year?

Amgen's SG&A decreased by 5.0% year-over-year, from $1.69B to $1.6B.

What is the long-term trend for Amgen's SG&A?

Over 4 years (2021 to 2025), Amgen's SG&A has grown at a 7.1% compound annual growth rate (CAGR), from $5.37B to $7.05B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Amgen AMGN SG&A

SG&A at other companies

Eli LillyLLY

$2.93B+18.9%

PfizerPFE

$2.96B-2.3%

Regeneron PharmaceuticalsREGN

$647.7M+2.3%

Rigel PharmaceuticalsRIGL

$30.65M+10.6%

Jazz PharmaceuticalsJAZZ

$352.7M-31.4%

Ultragenyx PharmaceuticalRARE

$88M+1.1%

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$190.42B+22.4%

Enterprise value$247.18B+16.4%

P/E24.4×-1.8×

P/S5.1×+0.6×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's SG&A?: Amgen (AMGN) reported SG&A of $1.6B in Q1 2026.
How has Amgen's SG&A changed year-over-year?: Amgen's SG&A decreased by 5.0% year-over-year, from $1.69B to $1.6B.
What is the long-term trend for Amgen's SG&A?: Over 4 years (2021 to 2025), Amgen's SG&A has grown at a 7.1% compound annual growth rate (CAGR), from $5.37B to $7.05B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.